Last Updated : January 24, 2020
Today, CADTH has issued final recommendations for:
glucagon (Baqsimi)
Indications: Severe hypoglycemic reactions
Recommendation: Reimburse with clinical criteria and/or conditions
Last Updated : January 24, 2020